DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Stifel Maintains Buy on Insmed, Lowers Price Target to $45

Stifel maintains Insmed (NASDAQ:INSM) with a Buy and lowers the price target from $55 to $45.

Benzinga · 03/17/2020 14:08

Stifel maintains Insmed (NASDAQ:INSM) with a Buy and lowers the price target from $55 to $45.